Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects (PPCVD)
This study is not yet open for participant recruitment.
Verified May 2011
by Ramathibodi Hospital
Study NCT01364675 Information provided by Ramathibodi Hospital
First Received on May 31, 2011. Last Updated on June 1, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pre-diabetes
Pre-hypertension
Additional conditions recognized in this trial
Cardiovascular Diseases
Diabetes Mellitus
Glucose Intolerance
Hypertension
Prediabetic State
Prehypertension
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperglycemia
Metabolic Diseases
Vascular Diseases
Interventions listed in this trial
Metformin+Enalapril+Simvastatin
Placebo tablet
Additional drug interventions recognized in this trial
Enalapril
Enalaprilat
Metformin
Simvastatin
More general drug interventions related to this trial
Angiotensin-Converting Enzyme Inhibitors
Anticholesteremic Agents
Antihypertensive Agents
Antimetabolites
Cardiovascular Agents
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Ramathibodi Hospital
Ubon Ratchathani Public Health Office, Thailand
National Health Security Office, Thailand
The Government Pharmaceutical Organization
Back to top of Main Content
